Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ondansetron × Lymphoid × Clear all

Phase

Status

Completed 7 Withdrawn 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Tumor-Agnostic 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 137 Rituximab 114 Etoposide 77 Vincristine 74 Doxorubicin 62 Cytarabine 61 Dexamethasone 58 Prednisone 54 fludarabine 51 Methotrexate 46 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 42 Lenalidomide 37 Gemcitabine 35 Radiotherapy 30 Melphalan 27 pegaspargase 22 Prednisolone 22 Ifosfamide 22 Busulfan 20 fludarabine phosphate 19 Cisplatin 19 Bendamustine Hydrochloride 19 Asparaginase 18 Peripheral Blood Stem Cell Transplantation 17 Carmustine 16 ibrutinib 15 Mercaptopurine 15 Filgrastim 15 Decitabine 15 Oxaliplatin 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00324467 2021-07-22

LYTPET

British Columbia Cancer Agency

Phase 2 Unknown

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡